Dificlir
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dificlir, covering 2024-09-30 to 2024-09-30. Get the full timeline:
Most recent: EMA Authorised: Dificlir (fidaxomicin) — Tillotts Pharma GmbH
1 regulatory and trial event tracked for Dificlir, covering 2024-09-30 to 2024-09-30. Get the full timeline:
Most recent: EMA Authorised: Dificlir (fidaxomicin) — Tillotts Pharma GmbH